Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Evaluation, assays and treatment of pKal-mediated disorders

Evaluation, assays and treatment of pKal-mediated disorders

US Patent 11892450 · Granted Feb 6, 2024

Estimated economic value: $124,265,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Assays for determining levels of plasma protease C1 inhibitor2020
Assays for determining levels of plasma protease C1 inhibitor2020
Plasma prekallikrein activation and kallikrein production assay2005
Plasma prekallikrein activation and kallikrein production assay2005
Method for the activation of blood coagulation factor XII2000
Method of inhibiting pro-inflammatory mediator release from basophils and mast c1995
Use of platelet factor 4 to treat inflammatory diseases1995